Experience the future of clinical weight management

The Qyral Weight Management Program has three simple steps:

1. Create a Qyral account and complete a medical survey online.
2. A Qyral-affiliated provider will review your information and prescribe your medication if approved.
3. Receive your medication from our mail-order pharmacy.

Our goal is to foster a long-term patient-provider relationship for personalized ongoing care. The program is ideal for individuals seeking consistent and tailored long-term care.

Our current Weight Management Program starts at $349 per month for semaglutide and $599 per month for tirzepatide, with an initial minimum subscription of 3 months. This price includes the cost of your medication and the doctor fee. Pricing may be subject to change after each 3 month billing cycle.

Qyral currently offers semaglutide and tirzepatide.

Semaglutide is an FDA-approved medication used for the treatment of type 2 diabetes and long-term weight management. Tirzepatide is an FDA-approved medication used for the treatment of type 2 diabetes. While it is primarily used as a medication for type 2 diabetes, tirzepatide can also be prescribed off-label for weight loss purposes. Tirzepatide has been shown in clinical trials to promote weight loss, although it is not FDA-approved for weight loss.

Both medications belong to a class of drugs called glucagon-like peptide-1 receptor agonists (GLP-1 RAs). They work by mimicking a hormone called GLP-1, which helps regulate blood sugar levels. Additionally, tirzepatide also mimics another hormone called glucose-dependent insulinotropic polypeptide (GIP). In clinical studies, the combined action of GLP-1 and GIP in tirzepatide has shown to be more effective for weight loss than semaglutide.

Off-label drug use refers to prescribing a medication for a purpose that is not officially approved by the FDA. It is legal and common for physicians to prescribe a drug for an off-label use when it is determined to be medically appropriate. In fact, according to the Agency for Healthcare Research and Quality, one in five prescriptions today are for off-label use.

Source

Semaglutide:
In 3 separate clinical trials involving non-diabetic patients, individuals who received semaglutide at a dose of 2.4 mg/week, along with following a reduced-calorie diet and increasing physical activity, experienced an average weight loss of 15% of their body weight over the course of 68 weeks.

Source

Tirzepatide:
In a double-blind, randomized, controlled trial, individuals who received regular tirzepatide at a dose of 15mg/week, along with following a reduced-calorie diet and increasing physical activity, experienced an average weight loss of 21% over the course of 72 weeks.

Source

Our telehealth service operates similarly to a traditional clinic, where payment covers the time and attention provided by our healthcare providers during your appointment. It's important to understand that payment does not guarantee the provision of a prescription medication. In cases where approval for the Qyral Weight Management Program is not granted, our healthcare providers may recommend alternative treatments that could be suitable for you.

If, for any reason, the Qyral-affiliated provider determines that you are not eligible to purchase the medication, you will receive a refund, with a deduction of $90 for the consultation that took place.

After each 3-month period, you will receive a reassessment to determine whether your current dosage should be maintained or adjusted. In the event that an change in your dosage is recommended, you will be moved to the appropriate tier, resulting in an adjustment to your subscription price. Additionally by agreeing to continue, you are committing to another 3-month subscription period.

When you purchase the weight loss medication, you will receive a 90-day supply and be billed monthly for the entire 3-month period. If you decide to continue the medication after 3 months, you will receive another 90-day supply and be billed for the next 3 months. To enhance affordability and convenience, we have divided the payments into monthly installments.

By purchasing the product, you commit to a minimum of three months of payments for the initial 90-day supply. Please note that based on your state of residence and the pharmacy servicing you, shipments will range from 30 to 90 days.

Towards the conclusion of your initial 90-day period, a follow-up will be conducted with your provider to assess your progress and make any required adjustments. We will not ship your next 90-day supply until the reassessment quiz is completed and turned in for the doctor’s review. While you will be auto-renewed and billed for another 3 months, the prescription will be held at the pharmacy until the quiz is completed and turned in.

The Qyral Weight Management Program offers different tiers with varying prices and amounts of medication. These tiers exist because individuals may require different doses based on their specific needs. Factors such as weight, medical history, and response to the medication influence the recommended dosage. More information on pricing and dosage can be found for semaglutide and tirzepatide on their respective pages.